Company Profile
Grey Wolf Health is an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics
Offers pharmaceuticals for the human and animal health markets. The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name. Its portfolio also includes sedative analgesic and reversing agents for companion animals under the SEDAJECT and ATAJECT names, prescription drugs under the THYRO-TABS CANINE name, and wound care products
Including medical grade tubes, viscose net dressings, alginate dressing, absorbent foam dressing, superabsorbent dressing, and silicone perforated tapes medical pet shirt protective wear products, such as pet shirt, pets boot, head cover, and leg sleeves, as well as disposables comprising syringes, needles, and IV catheters; and nutraceuticals
Equine health products. Formerly known as Grey Wolf Animal Health Corp., the company rebranded as Grey Wolf Health Corp. in June 2026. The company is headquartered in Toronto, Canada.